Overview

Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs in different combinations and combining them with interferon alfa and G-CSF may kill more tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of different combination chemotherapy regimens in treating patients with advanced stomach cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Eastern Cooperative Oncology Group
Collaborator:
National Cancer Institute (NCI)
Treatments:
Docetaxel
Doxorubicin
Fluorouracil
Hydroxyurea
Interferon-alpha
Interferons
Lenograstim
Liposomal doxorubicin